Amylou C. Dueck - Publications, H-index & Citations

Back

Amylou C. Dueck

mayo clinic

76H-index

771Paper Count

2.7WCitation Count

Published Papers 162

Publication Date

Psychometric Evaluation of the PRO-CTCAE Average Composite Score: Reliability, Responsiveness, Known-Groups Validity, and Sensitivity to Group Differences

Cancers

IF4.4

2026-07-23

OAAI

Minji K. Lee; Amylou C. Dueck; Blake T. Langlais; Gina L. Mazza; Gita Thanarajasingam; Allison M. Deal; Brie N. Noble; Lauren Rogak; Tito R. Mendoza; Sandra A. Mitchell; Ethan Basch

Save

Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event Burden

Cancers 2025, Vol. 17, Page 3459

IF4.4

2025-10-29

OAAI

Minji K. Lee; Sandra A. Mitchell; Ethan Basch; Allison M. Deal; Blake T. Langlais; Gita Thanarajasingam; Brenda F. Ginos; Lauren Rogak; Tito R. Mendoza; Antonia V. Bennett; Brie N. Noble; Gina L. Mazza; Amylou C. Dueck

Save

Methods for implementing and reporting the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to measure patient-reported adverse events in cancer clinical trials

Cancer

IF5.1

2025-10-22

OAAI

Amylou C. Dueck PhD; Gita Thanarajasingam MD; Lauren Rogak MA; Gina L. Mazza PhD; Blake T. Langlais MS; Brie N. Noble MS; Brenda F. Ginos MS; Carolyn Mead-Harvey MS; Claire I. Yee PhD; Minji K. Lee PhD; Allison M. Deal MS; Eric A. Meek BA; Ethan Basch MD, MSc

Save

Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)

Annals of Oncology

IF65.4

2025-10-17

OAAI

E.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele

Save

Use of patient-reported outcomes version of the common terminology criteria for adverse events in oncology clinical trials

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS

IF1.4

2025-09-01

OAAI

Rogak, Lauren; Forschmiedt, Jamie K.; Basch, Ethan; Mazza, Gina L.; Lee, Minji K.; Meek, Eric A.; Ginos, Brenda; Langlais, Blake T.; Noble, Brie N.; Deal, Allison M.; Yee, Claire; Thanarajasingam, Gita; Dueck, Amylou C.

Save

Assessing Physical Function in Transplantation and CAR-T Recipients: Expert Recommendations from the Survivorship, Aging and Biobehavioral Special Interest Groups of ASTCT

Transplantation and Cellular Therapy

IF4.4

2025-06-01

PREAI

Shatha Farhan; Vanessa E. Kennedy; Manuel R. Espinoza-Gutarra; Hannah Lust; Maria Silvina Odstrcil Bobillo; Adam Yuh Lin; Rebecca L. Olin; Richard J. Lin; Kelly E. Rentscher; Mallory R. Taylor; Lathika Mohanraj; William A. Wood; Hemant S. Murthy; Nuasheen Ahmed; Amylou C. Dueck; Rachel Phelan; Debra Lynch Kelly; Carrie Yuen; Pashna N. Munshi; Hélène Schoemans; Betty K. Hamilton; Catherine Lee; Anthony D. Sung

Save

Beyond maximum grade: advancing the measurement and analysis of adverse events in malignant haematology trials in the modern era

lancet haematology

IF0

2025-05-28

PREAI

Ajay Major; Amylou C Dueck; Gita Thanarajasingam

Save

Beyond maximum grade: using patient-generated data to inform tolerability of treatments for haematological malignancies

lancet haematology

IF0

2025-05-28

PREAI

Vishal Bhatnagar; Amylou C Dueck; Fabio Efficace; Paul Kluetz; Lori Minasian; Galina Velikova; Caitlin Drew; Gita Thanarajasingam

Save

Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series

lancet haematology

IF0

2025-05-28

PREAI

Gita Thanarajasingam; Ajay Major; Vishal Bhatnagar; Amylou C Dueck; Karin E Smedby; Tarec Christoffer El-Galaly; Jan Geissler; Thomas Habermann; Paul G Kluetz; John F Seymour; Kyriaki Tzogani; Diego Villa; Paul J Bröckelmann

Save

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13])

BREAST CANCER RESEARCH

IF5.6

2025-01-23

OAAI

Demichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H.; Pfeiler, G.; Zdenkowski, N.; Wolff, A.; Bellet-Ezquerra, M.; Winer, E.; Balic, M.; Miller, K.; Colleoni, M.; Lake, D.; Rubovsky, G.; Cameron, D.; Balko, J.; Singer, C. F.; Nowecki, Z.; Iwata, H.; Wolmark, N.; Parraga, K. A.; Rugo, H.; Steger, G. G.; Traina, T.; Werutsky, G.; Czajkowska, D.; Metzger, O.; El-Abed, S.; Theall, K. P.; Lu, R. D.; O'Brien, P.; Fesl, C.; Mayer, E.; Gnant, M.

Save

Development and Validation of Emoji Response Scales for Assessing Patient-Reported Outcomes

JCO CLINICAL CANCER INFORMATICS

IF2.8

2025-01-01

PREAI

Thompson, Carrie A.; Novotny, Paul J.; Yost, Kathleen; Bartz, Alicia C.; Rogak, Lauren; Dueck, Amylou C.

Save

Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)

QUALITY OF LIFE RESEARCH

IF2.7

2024-11-06

OAAI

Lee, Minji K.; Mitchell, Sandra A.; Basch, Ethan; Mazza, Gina L.; Langlais, Blake T.; Thanarajasingam, Gita; Ginos, Brenda F.; Rogak, Lauren; Meek, Eric A.; Jansen, Jennifer; Deal, Allison M.; Carr, Philip; Blinder, Victoria S.; Jonsson, Mattias; Mody, Gita N.; Mendoza, Tito R.; Bennett, Antonia V.; Schrag, Deborah; Dueck, Amylou C.

Save

TP53 Alterations Confer Increased Risk of Leukemic Transformation and Worse Survival As Compared to High Molecular Risk Mutations in Patients with Myeloproliferative Neoplasms

BLOOD

IF23.1

2024-11-05

PREAI

Handa, Shivani; Riazat-Kesh, Yosef Joseph Rene Amel; Butterfield, Richard J.; Sivakumar, Ganesh; Venugopal, Sangeetha; Mcgovern, Erin; Feld, Jonathan; Tremblay, Douglas; Elghaity-Beckley, Sebastian; Kremyanskaya, Marina; Mascarenhas, John O.; Langlais, Blake; Mazza, Gina L.; Nathan, Daniel I.; Tripodi, Joseph; Najfeld, Vesna; Dueck, Amylou C.; Rampal, Raajit; Hoffman, Ronald; Marcellino, Bridget Kelly

Save

Incorporating Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) into Dose Review in a Phase I Clinical Trial

BLOOD

IF23.1

2024-11-05

PREAI

Mead-Harvey, Carolyn; Noble, Brie N.; Yee, Claire; Mazza, Gina L.; Langlais, Blake; Patel, Sheetal; Trask, Peter; Rogak, Lauren; Basch, Ethan; Dueck, Amylou C.; Thanarajasingam, Gita

Save

Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

ECLINICALMEDICINE

IF10

2024-10-01

OAAI

Yap, Christina; Aiyegbusi, Olalekan Lee; Alger, Emily; Basch, Ethan; Bell, Jill; Bhatnagar, Vishal; Cella, David; Collis, Philip; Dueck, Amylou C.; Gilbert, Alexandra; Gnanasakthy, Ari; Greystoke, Alastair; Hansen, Aaron R.; Kamudoni, Paul; Kholmanskikh, Olga; King-Kallimanis, Bellinda L.; Krumholz, Harlan; Minchom, Anna; O'Connor, Daniel; Petrie, Joan; Piccinin, Claire; Rantell, Khadija Rerhou; Rauz, Saaeha; Retzer, Ameeta; Rizk, Steven; Wagner, Lynne; Sasseville, Maxime; Seymour, Lesley K.; Weber, Harald A.; Wilson, Roger; Calvert, Melanie; Peipertf, John Devin

Save

Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)-Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD)

ANNALS OF SURGERY

IF6.4

2024-07-29

PREAI

Chang, George J.; Gunn, Heather J.; Barber, Anne K.; Lowenstein, Lisa M.; Dohan, Daniel; Broering, Jeanette; Dockter, Travis; Tan, Angelina D.; Dueck, Amylou; Chow, Selina; Neuman, Heather; Finlayson, Emily

Save

At what COST?: A prospective longitudinal cohort assessment of financial toxicity, quality of life, and associated risk factors in patients with plasma cell disorders

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2024-07-05

PREAI

Warsame, Rahma M.; Schmidt, Walker M.; Dispenzieri, Angela; Dueck, Amylou C.

Save

Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma

SCIENTIFIC REPORTS

IF3.9

2024-06-27

OAAI

Cleeland, Charles S.; Keating, Karen N.; Cuffel, Brian; Elbi, Cem; Siegel, Jonathan M.; Gerlinger, Christoph; Symonds, Tara; Sloan, Jeff A.; Dueck, Amylou C.; Bottomley, Andrew; Wang, Xin Shelley; Williams, Loretta A.; Mendoza, Tito R.

Save

Optimization of alert notifications in electronic patient-reported outcome (ePRO) remote symptom monitoring systems (AFT-39)

QUALITY OF LIFE RESEARCH

IF2.7

2024-05-21

PREAI

Mazza, Gina L.; Dueck, Amylou C.; Ginos, Brenda; Jansen, Jennifer; Deal, Allison M.; Carr, Philip; Blinder, Victoria S.; Thanarajasingam, Gita; Jonsson, Mattias; Lee, Minji K.; Rogak, Lauren J.; Mody, Gita N.; Schrag, Deborah; Basch, Ethan

Save

The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2023-12-01

OAAI

Smith, Katherine E. R.; Pritzl, Stephanie L.; Yu, Wei; Bara, Ilze; Thanarajasingam, Gita; Kaul, Monika D.; Williams, Kirstin A.; Dueck, Amylou C.; Mans, Aaron S.

Save

Research Directions